Tag: USFDA
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
In-house legal teams that adapt now will be better placed for the final judgment after the first ruling on AI training and copyright
Follow us on LinkedIn